Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Diagnostic Products (NYSE:DP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 17Dividend payment of $0.06
Location
5700 West 96th Street
Los Angeles, CA 90045
Phone: (310) 645-8200
Fax: (310) 645-9999
Email: webmaster@dpconline.com
Employees (last reported count): 1,767
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 41%
·Over the last 6 months:
 · 11 insider sells; 68.0K shares
  (0.6% of insider shares)
·Institutional: 55% (94% of float)
(251 institutions)
·Net Inst. Buying: 879.0K shares (+5.33%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Diagnostic Products Corporation develops, manufactures and markets medical immunodiagnostic test kits that utilize technology derived from immunology and molecular biology and automated laboratory instruments that perform the tests. The Company's products are used by hospital, clinical, veterinary, research and forensic laboratories, as well as doctors' offices, to obtain precise and rapid identification and measurement of hormones, drugs, viruses, bacteria and other substances present in body fluids and tissues at infinitesimal concentrations. The principal clinical applications of the Company's more than 400 assays (tests) relate to the diagnosis and management of thyroid disorders, anemia, reproductive disorders, diabetes, allergies, bone metabolism, infectious diseases, substance abuse and certain types of cancer. The Company's kits are used for in vitro testing, meaning the tests are performed outside of the body, typically in a test tube.
More from Market Guide: Expanded Business Description

Financial Summary
DP develops, manufactures and markets medical immunodiagnostic test kits which utilize state-of-the-art technology derived from immunology and molecular biology, and automated laboratory instruments. For the six months ended 6/30/01, revenues rose 14% to $140.6 million. Net income rose 39% to $18.6 million. Revenues reflect a higher volume of IMMULITE products shipped and sold. Net income reflects increased gross margins driven by manufacturing efficiencies.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Michael Ziering, 44
Chairman, CEO
$486K
Sidney Aroesty, 54
Sr. VP, COO, Director
318K
Said Shami, 58
Sr. VP of R&D and CSO
354K
James Brill, 49
VP-Fin.
262K
Kathy Maugh, 56
VP - Technical Operations
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:DPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Oct-2000
$18.657
Recent Price$39.25 
52-Week High
on 6-June-2001
$41.775
Beta0.10 
Daily Volume (3-month avg)97.5K
Daily Volume (10-day avg)55.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+84.7%
52-Week Change
relative to S&P500
+147.8%
Share-Related Items
Market Capitalization$1.11B
Shares Outstanding28.2M
Float16.6M
Dividends & Splits
Annual Dividend (indicated)$0.24 
Dividend Yield0.61%
Last Split: 2 for 1 on 19-June-2001
Per-Share Data
Book Value (mrq)$8.57 
Earnings (ttm)$1.15 
Earnings (mrq)$0.34 
Sales (ttm)$9.17 
Cash (mrq)$0.65 
Valuation Ratios
Price/Book (mrq)4.58 
Price/Earnings (ttm)34.01 
Price/Sales (ttm)4.28 
Income Statements
Sales (ttm)$265.6M
EBITDA (ttm)$71.2M
Income available to common (ttm)$33.5M
Profitability
Profit Margin (ttm)13.1%
Operating Margin (ttm)18.7%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)12.61%
Return on Equity (ttm)14.79%
Financial Strength
Current Ratio (mrq)3.13 
Debt/Equity (mrq)0.06 
Total Cash (mrq)$18.3M
Short Interest
As of 8-Aug-2001
Shares Short272.0K
Percent of Float1.6%
Shares Short
(Prior Month)
169.0K
Short Ratio2.64 
Daily Volume103.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.